Both of those articles are really dealing only with specific investigations rather than the broad possibilities of use of embryonic derived stem cells in new treatment strategies.
I base my opinion on my contact with catherine verfaillie. I was interviewing for an opening in her lab and I asked if she thought her work implied that research involving embryonic stem cells should be curtailed if those resources could then be applied to adult stem cell research and she made clear that she felt that embryonic stem cells could probably lead to clinically useful treatment strategies for some applications earlier than could be accomplished by relying entirely on adult stem cells. This was only 4 years ago.
Comment